基于电力消耗评估质子治疗碳足迹及可能的减缓策略
该研究评估2020年7月至2021年6月使用Mevion质子系统治疗的185例患者共5176次分割的能耗与碳足迹。BeamOn时间碳足迹为4.17公吨二氧化碳当量,每患者疗程23 kg;质子项目年碳足迹253.7吨,每患者归因1372 kg。作者提出减少浪费、减少通勤、高效用电和可再生能源等减缓与抵消策略。
要点
- BeamOn时间碳足迹为4.17公吨二氧化碳当量,每患者疗程23 kg。
- 质子项目年碳足迹253.7吨二氧化碳当量,每患者归因1372 kg。
- 碳足迹因疾病而异,乳腺癌每疗程60 kg,前列腺癌12 kg。
核心结论
- 碳足迹因所治疗疾病而异,平均每患者23 kg二氧化碳当量,质子项目为253.7吨二氧化碳当量。
- 作者认为放射肿瘤科医生有多种减少、减缓与抵消策略可供探索,如减少浪费、减少治疗通勤、高效能源使用和可再生电力使用。
研究设计与样本
- 评估2020年7月至2021年6月期间使用Mevion质子系统治疗的患者。
- 将电流测量值转换为千瓦电力消耗,并回顾患者疾病、剂量、分割次数和束流持续时间。
- 使用美国环境保护署计算器将电力消耗转换为吨二氧化碳当量,用于基于范围的碳足迹核算。
主要发现
- 共治疗185例患者,交付5176次分割,平均28次。
- 待机/夜间模式功耗55.8 kW,BeamOn期间64.4 kW,年总计490 MWh。
- BeamOn时间为149.6小时,BeamOn消耗占机器总量的2%。
- 每患者功耗52 kWh,乳腺癌最高为140 kWh,前列腺癌最低为28 kWh。
- 行政区域年功耗约96 MWh,项目总计586 MWh。
关键数值与推荐
- BeamOn时间碳足迹为4.17公吨二氧化碳当量,每患者疗程23 kg;乳腺癌60 kg,前列腺癌12 kg。
- 机器年碳足迹为212.2吨二氧化碳当量,质子项目为253.7吨二氧化碳当量,每患者归因足迹为1372 kg二氧化碳当量。
- 项目相应的二氧化碳当量抵消可为种植4192棵新树并生长10年,即每患者23棵树。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: There is increasing concern about rising carbon dioxide (CO2) emissions and their hazardous effect on human health. This study quantifies the energy utilization of proton therapy, assesses the corresponding carbon footprint, and discusses possible offsetting strategies toward carbon-neutral health care operations. METHODS AND MATERIALS: Patients treated between July 2020 and June 2021 using the Mevion proton system were evaluated. Current measurements were converted to kilowatts of power consumption. Patients were reviewed for disease, dose, number of fractions, and duration of beam. The Environmental Protection Agency calculator was used to convert power consumption to tons of CO2 equivalent (CO2e) for scope-based carbon footprint accounting. RESULTS: There were 185 patients treated and a total of 5176 fractions delivered (average, 28). Power consumption was 55.8 kW in standby/night mode and 64.4 kW during BeamOn, for an annual total of 490 MWh. BeamOn time was 149.6 hours, and BeamOn consumption accounted for 2% of the machine total. Power consumption was 52 kWh per patient (breast, highest at 140 kWh; prostate, lowest at 28 kWh). Annual power consumption of the administrative areas was approximately 96 MWh, for a program total of 586 MWh. The carbon footprint for BeamOn time was 4.17 metric tons of CO2e, or 23 kg per patient course (breast cancer, 60 kg; prostate, 12 kg). The annual carbon footprint for the machine was 212.2 tons CO2e, and for the proton program, 253.7 tons CO2e, with an attributed footprint of 1372 kg CO2e per patient. The corresponding CO2e offset for the program could be 4192 new trees planted and grown for 10 years (23 trees per patient). CONCLUSIONS: The carbon footprint varied by disease treated. On average, the carbon footprint was 23 kg of CO2e per patient and 253.7 tons of CO2e for the proton program. There are a number of reduction, mitigation, and offset strategies possible for radiation oncologists that should be explored, such as waste minimization, less treatment commuting, efficient energy use, and renewable electricity power use.
引用
- Dvorak T, Meeks S, Dvorak L, et al. Evaluating Carbon Footprint of Proton Therapy Based on Power Consumption and Possible Mitigation Strategies. Int J Radiat Oncol Biol Phys. 2023. PMID: 37244624. doi:10.1016/j.ijrobp.2023.05.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。